OR32. Efficacy and Safety of Therapeutic Versus Prophylactic Dose of Anticoagulation in Hospitalized Patients with Severe COVID-19 Pneumonia and Coagulopathy: An Open-Label, Randomized Controlled Trial

被引：0

作者：

Adrian, L. H. ^{[1
]}

Hutomo, S. A. ^{[1
]}

Negari, A. D. S. ^{[1
]}

机构：

[1] Syarifah Ambami Rato Ebu Gen Hosp, Dept Cardiol & Vasc Med, East Java, Indonesia

来源：

关键词：

COVID-19; coagulopathy; therapeutic; anticoagulant; efficacy; safety;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：1